ClinVar Miner

Submissions for variant NM_078470.6(COX15):c.131G>A (p.Ser44Asn)

gnomAD frequency: 0.00016  dbSNP: rs141506146
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000398229 SCV000359747 uncertain significance Leigh syndrome 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Invitae RCV001859775 SCV002222128 uncertain significance not provided 2022-08-23 criteria provided, single submitter clinical testing This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 44 of the COX15 protein (p.Ser44Asn). This variant is present in population databases (rs141506146, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with COX15-related conditions. ClinVar contains an entry for this variant (Variation ID: 298420). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Fulgent Genetics, Fulgent Genetics RCV002504048 SCV002816641 uncertain significance Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2 2021-11-07 criteria provided, single submitter clinical testing
Ambry Genetics RCV002522137 SCV003534760 uncertain significance Inborn genetic diseases 2021-11-09 criteria provided, single submitter clinical testing The c.131G>A (p.S44N) alteration is located in exon 2 (coding exon 2) of the COX15 gene. This alteration results from a G to A substitution at nucleotide position 131, causing the serine (S) at amino acid position 44 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.